Insiders · Profile

LOWE CHRISTOPHER P.

COO & Chief Financial Officer at Quince Therapeutics. Filing since 28 Jun 2021. CIK 0001376260

Company
Date
Role
Action
Shares
Amount
Of holding
5 Oct 2021
COO & Chief Financial Officer
Sold, plan not stated
4,963
$488.86K
7.6%
16 Aug 2021
COO & Chief Financial Officer
Sold, plan not stated
22,000
$2.10M
42.3%
28 Jun 2021
COO & Chief Financial Officer
Sold, plan not stated
20,000
$1.08M
100%
3 decisions on file.